{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:42:43Z","timestamp":1791117763485,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1186\/1756-9966-28-27","type":"journal-article","created":{"date-parts":[[2009,2,25]],"date-time":"2009-02-25T19:14:11Z","timestamp":1235589251000},"source":"Crossref","is-referenced-by-count":40,"title":["Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors"],"prefix":"10.1186","volume":"28","author":[{"given":"Ahmed S","family":"Abdulamir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rand R","family":"Hafidh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haider S","family":"Kadhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah","family":"Abubakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,25]]},"reference":[{"key":"114_CR1","first-page":"113","volume":"3","author":"T Shirai","year":"1993","unstructured":"Shirai T: Etiology of bladder cancer. Semin Urol. 1993, 3: 113-116.","journal-title":"Semin Urol"},{"key":"114_CR2","first-page":"353","volume-title":"General Urology","author":"PR Carroll","year":"1995","unstructured":"Carroll PR: Urothelial Carcinoma: Cancers of the Bladder Ureter & Renal Pelvis. General Urology. Edited by: Tanagho EA, McAninch JW. 1995, Philadelphia: Prentice-Hall International Inc, 353-372. 14","edition":"14"},{"key":"114_CR3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-5347(17)35014-0","volume":"151","author":"AA Sandberg","year":"1994","unstructured":"Sandberg AA, Berger CS: Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer. J Urol. 1994, 151: 545-560.","journal-title":"J Urol"},{"key":"114_CR4","first-page":"29","volume":"1","author":"GC Ejezie","year":"1991","unstructured":"Ejezie GC: The epidemiology and control of schistosomiasis in Africa. Nigeria J Med. 1991, 1: 29-30.","journal-title":"Nigeria J Med"},{"key":"114_CR5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4269\/ajtmh.2000.62.42","volume":"62","author":"MA El-Harvey","year":"2000","unstructured":"El-Harvey MA, Amr MM, Abdel-Rahman AB: The epidemiology of schistosomiasis in Egypt: Gharbia Governorate. Am J Trop Med Hyg. 2000, 62: 42-48.","journal-title":"Am J Trop Med Hyg"},{"key":"114_CR6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1128\/CMR.12.1.97","volume":"12","author":"MH Mostafa","year":"1999","unstructured":"Mostafa MH, Sheweita SA, O'Connor PJ: Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev. 1999, 12: 97-111.","journal-title":"Clin Microbiol Rev"},{"key":"114_CR7","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/carcin\/16.5.1181","volume":"16","author":"W Warren","year":"1995","unstructured":"Warren W, Biggs PJ, el-Baz M, Ghoneim MA, Stratton MR, Venitt S: Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours. Carcinogenesis. 1995, 16: 1181-1189. 10.1093\/carcin\/16.5.1181.","journal-title":"Carcinogenesis"},{"key":"114_CR8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0022-5347(17)38700-1","volume":"142","author":"L Del Senno","year":"1989","unstructured":"Del Senno L, Maestri I, Piva R, Hanau S, Reggiani A, Romano A, Russo G: Differential hypomethylation of the c- myc protooncogene in bladder cancers at different stages and grades. J Urol. 1989, 142: 146-149.","journal-title":"J Urol"},{"key":"114_CR9","first-page":"1461","volume":"15","author":"SG Williams","year":"2001","unstructured":"Williams SG, Buscarini M, Stein JP: Molecular markers for diagnosis, staging and prognosis of bladder cancer. Oncology. 2001, 15: 1461-1484.","journal-title":"Oncology"},{"key":"114_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00345-007-0202-7","volume":"25","author":"GJ Villares","year":"2007","unstructured":"Villares GJ, Zigler M, Blehm K, Bogdan C, McConkey D, Colin D, Bar-Eli M: Targeting EGFR in bladder cancer. World J Urol. 2007, 25: 573-579. 10.1007\/s00345-007-0202-7.","journal-title":"World J Urol"},{"key":"114_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1269\/jrr.07014","volume":"48","author":"AJ Colquhoun","year":"2007","unstructured":"Colquhoun AJ, McHugh LA, Tulchinsky E, Kriajevska M, Mellon JK: Combination treatment with ionising radiation and gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor (EGFR) inhibitor, significantly inhibits bladder cancer cell growth in vitro and in vivo. J Radiat Res (Tokyo). 2007, 48: 351-360. 10.1269\/jrr.07014.","journal-title":"J Radiat Res (Tokyo)"},{"key":"114_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00345-007-0197-0","volume":"25","author":"AP Mitra","year":"2007","unstructured":"Mitra AP, Birkhahn M, Cote RJ: p53 and retinoblastoma pathways in bladder cancer. World J Urol. 2007, 25: 563-571. 10.1007\/s00345-007-0197-0.","journal-title":"World J Urol"},{"key":"114_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S1078-1439(03)00176-5","volume":"22","author":"TS Tzai","year":"2004","unstructured":"Tzai TS, Tsai YS, Chow NH: The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer. Urol Oncol. 2004, 22: 112-118.","journal-title":"Urol Oncol"},{"key":"114_CR14","first-page":"67","volume-title":"Apoptosis and cancer","author":"CO Bellamy","year":"1997","unstructured":"Bellamy CO, Malcomson R, Wyllie A: The role of p53 in apoptosis and cancer. Apoptosis and cancer. Edited by: Martin SJ. 1997, Basel: Karger Landes systems, 67-71. 2","edition":"2"},{"key":"114_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.canlet.2005.05.039","volume":"237","author":"HJ Cho","year":"2006","unstructured":"Cho HJ, Kim JK, Kim KD, Yoon HK, Cho MY, Park YP, Jeon JH, Lee ES, Byun SS, Lim HM: Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells. Cancer Lett. 2006, 237: 56-66. 10.1016\/j.canlet.2005.05.039.","journal-title":"Cancer Lett"},{"key":"114_CR16","first-page":"112","volume-title":"Apoptosis and cancer","author":"JC Reed","year":"1997","unstructured":"Reed JC: Bcl-2 Family proteins: Role in dysregulation of apoptosis and chemoresistance in cancer. Apoptosis and cancer. Edited by: Martin SJ. 1997, Basel: Karger Landes systems, 112-116. 2","edition":"2"},{"key":"114_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jcp.55.6.467","volume":"55","author":"CF Lindboe","year":"2002","unstructured":"Lindboe CF, Torp SH: Comparison of Ki-67 equivalent antibodies. J Clin Pathol. 2002, 55: 467-471.","journal-title":"J Clin Pathol"},{"key":"114_CR18","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/S0002-9440(10)64472-0","volume":"161","author":"M Srinivasan","year":"2002","unstructured":"Srinivasan M, Sedmak D, Jewell S: Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol. 2002, 161: 1961-1971.","journal-title":"Am J Pathol"},{"key":"114_CR19","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1002\/1097-0142(19811215)48:12<2643::AID-CNCR2820481216>3.0.CO;2-C","volume":"48","author":"MN El Bolkainy","year":"1981","unstructured":"El Bolkainy MN, Mokhtar NM, Ghoneim MA, Hussein MH: The impact of schistosomiasis on the pathology of bladder carcinoma. Cancer. 1981, 48: 2643-2648. 10.1002\/1097-0142(19811215)48:12<2643::AID-CNCR2820481216>3.0.CO;2-C.","journal-title":"Cancer"},{"key":"114_CR20","first-page":"197","volume":"18","author":"HN Tawfik","year":"1987","unstructured":"Tawfik HN: Carcinoma of the urinary bladder associated with schistosomiasis in Egypt: the possible causal relationship. Princess Takamatsu Symp. 1987, 18: 197-209.","journal-title":"Princess Takamatsu Symp"},{"key":"114_CR21","first-page":"1329","volume":"10","author":"A Pich","year":"2003","unstructured":"Pich A, Margaria M, Chiusa L, Bortolin P, Palestro G: Relationship between AgNORs, MIB-1 and oncogene expression in male breast carcinoma and papillary superficial bladder neoplasm. Oncology Reports. 2003, 10: 1329-1335.","journal-title":"Oncology Reports"},{"key":"114_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1046\/j.1464-410X.1997.30717.x","volume":"79","author":"KS Chaudhary","year":"1997","unstructured":"Chaudhary KS, Lu QL, Abel PD, Khandan-Nia N, Shoma AM, el Baz M, Stamp GW, Lalani EN: Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder. Br J Urol. 1997, 79: 78-84.","journal-title":"Br J Urol"},{"issue":"2","key":"114_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.humpath.2003.10.006","volume":"35","author":"KM Badr","year":"2004","unstructured":"Badr KM, Nolen JD, Derose PB, Cohen C: Muscle invasive schistosomal squamous cell carcinoma of the urinary bladder: frequency and prognostic significance of p53, BCL-2, HER2\/neu, and proliferation (MIB-1). Hum Pathol. 2004, 35 (2): 184-189. 10.1016\/j.humpath.2003.10.006.","journal-title":"Hum Pathol"},{"key":"114_CR24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/BF02550226","volume":"30","author":"F Atug","year":"1998","unstructured":"Atug F, Turkeri L, Ozyurek M, Akdas A: bcl-2 and p53 overexpression as associated risk factors in TCC of the bladder. Int Urol Nephrol. 1998, 30: 455-461. 10.1007\/BF02550226.","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"114_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/BF02893365","volume":"12","author":"A Helal Tel","year":"2006","unstructured":"Helal Tel A, Fadel MT, El-Sayed NK: Human papilloma virus and p53 expression in bladder cancer in Egypt: relationship to schistosomiasis and clinicopathologic factors. Pathol Oncol Res. 2006, 12 (3): 173-178. 10.1007\/BF02893365.","journal-title":"Pathol Oncol Res"},{"key":"114_CR26","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S1470-2045(05)70315-6","volume":"6","author":"N Malats","year":"2005","unstructured":"Malats N, Bustos A, Nascimento CM, Fernandez F, Rivas M, Puente D, Kogevinas M, Real FX: p53 as a prognostic marker for bladder cancer: a meta-analysis and review. Lancet Oncol. 2005, 6: 678-686. 10.1016\/S1470-2045(05)70315-6.","journal-title":"Lancet Oncol"},{"issue":"5","key":"114_CR27","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/S0022-5347(05)66332-X","volume":"165","author":"A Haitel","year":"2001","unstructured":"Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M: Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2. J Urol. 2001, 165 (5): 1481-1487. 10.1016\/S0022-5347(05)66332-X.","journal-title":"J Urol"},{"key":"114_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0009-8981(00)00317-X","volume":"300","author":"S Eissa","year":"2000","unstructured":"Eissa S, Ali-Labib R, Khalifa A: Deletion of p16 and p15 genes In schistosomiasis-associated bladder cancer (SABC). Clin Chim Acta. 2000, 300: 159-169. 10.1016\/S0009-8981(00)00317-X.","journal-title":"Clin Chim Acta"},{"key":"114_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000113792","volume":"75","author":"A Brunner","year":"2008","unstructured":"Brunner A, Verdorfer I, Prelog M, Mayerl C, Mikuz G, Tzankov A: Large-scale analysis of cell cycle regulators in urothelial bladder cancer identifies p16 and p27 as potentially useful prognostic markers. Pathobiology. 2008, 75: 25-33. 10.1159\/000113792.","journal-title":"Pathobiology"},{"key":"114_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/ijc.2910620302","volume":"62","author":"N Ramchurren","year":"1995","unstructured":"Ramchurren N, Cooper K, Summerhayes IC: Molecular events underlying schistosomiasis-related bladder cancer. Int J Cancer. 1995, 62: 237-244. 10.1002\/ijc.2910620302.","journal-title":"Int J Cancer"},{"key":"114_CR31","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/path.1567","volume":"203","author":"SJ Chatterjee","year":"2004","unstructured":"Chatterjee SJ, George B, Goebell PJ, Alavi-Tafreshi M, Shi SR, Fung YK, Jones PA, Cordon-Cardo C, Datar RH, Cote RJ: Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer. J Pathol. 2004, 203: 762-770. 10.1002\/path.1567.","journal-title":"J Pathol"},{"issue":"2","key":"114_CR32","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.urology.2007.12.063","volume":"72","author":"DA Hameed","year":"2008","unstructured":"Hameed DA, Abdel Raheem AM, Mosad E, Hammouda HM, Kamel NA, Abdel Aziz MA: Bcl-XL and Bcl-2 expression in bilharzial squamous cell carcinoma of the urinary bladder: which protein is prognostic?. Urology. 2008, 72 (2): 374-378. 10.1016\/j.urology.2007.12.063.","journal-title":"Urology"},{"key":"114_CR33","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1007\/BF00942047","volume":"25","author":"BJ Schmitz-Drager","year":"1997","unstructured":"Schmitz-Drager BJ, Schulz WA, Jurgens B, Gerharz CD, van Roeyen CR, Bultel H: c-myc in bladder cancer, clinical findings and analysis of mechanism. Urol Res. 1997, 25: S45-S49. 10.1007\/BF00942047.","journal-title":"Urol Res"},{"key":"114_CR34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/path.1711750208","volume":"175","author":"PK Lipponen","year":"1995","unstructured":"Lipponen PK: Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer. J Pathol. 1995, 175: 203-210. 10.1002\/path.1711750208.","journal-title":"J Pathol"},{"key":"114_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1136\/jcp.51.8.583","volume":"51","author":"MF Tungekar","year":"1998","unstructured":"Tungekar MF, Linehan J: Patterns of expressions of transforming growth factor and epidermal growth factor receptor in squamous cell lesions of the urinary bladder. J Clin Pathol. 1998, 51: 583-587. 10.1136\/jcp.51.8.583.","journal-title":"J Clin Pathol"},{"key":"114_CR36","first-page":"643","volume":"52","author":"EA Masliukova","year":"2006","unstructured":"Masliukova EA, Pozharisskii KM, Karelin MI, Startsev V, Ten VP: [Role of Ki-67, mutated gene-suppressor p53 and HER-2neu oncoprotein in the prognosis for the clinical course of bladder cancer]. Vopr Onkol. 2006, 52: 643-648.","journal-title":"Vopr Onkol"},{"key":"114_CR37","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0046-8177(98)90225-8","volume":"29","author":"L Nakopoulou","year":"1998","unstructured":"Nakopoulou L, Vourlakou C, Zervas A: The prevalence of bcl-2, p53 and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates. Hum Pathol. 1998, 29: 146-154. 10.1016\/S0046-8177(98)90225-8.","journal-title":"Hum Pathol"},{"key":"114_CR38","first-page":"4079","volume":"5","author":"C Pfister","year":"1999","unstructured":"Pfister C, Moore L, Allard P, Larue H, Fradet Y: Predictive Value of Cell Cycle Markers p53, MDM2, p21, and Ki-67 in Superficial Bladder Tumor Recurrence. Clini Ca Res. 1999, 5: 4079-4084.","journal-title":"Clini Ca Res"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-28-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-9966-28-27\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-28-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T08:07:01Z","timestamp":1548230821000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/1756-9966-28-27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["114"],"URL":"https:\/\/doi.org\/10.1186\/1756-9966-28-27","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2]]},"article-number":"27"}}